Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reirradiation and hyperthermia with or without cisplatin for locally recurrent breast cancer in a previously irradiated area
NL-OMON27367Phase 2Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cisplatin in breast cancer (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Local control rate. Started Dec 2012; status: active, not recruiting.
02
Drugs
cisplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON27367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27367.